If you are fortunate enough to have $4,000 to invest in the share market, then I would consider investing it across the four top ASX shares listed below.
I believe each of them has the potential to generate market beating returns over the next few years due to their solid business models and positive outlooks.
Here's why I would invest $1,000 into all four of them:
Appen Ltd (ASX: APX)
Appen is a provider of human annotated dataset development services to some of the world's biggest tech companies such as Facebook and Microsoft. As the company services machine learning and artificial intelligence markets (which are expected to grow rapidly over the next decade), I believe it is well placed to continue growing its earnings at strong rate for the many years to come.
Commonwealth Bank of Australia (ASX: CBA)
The shares of Australia's largest bank have fallen very heavily over the last three months. While this decline is not completely unwarranted, I think the selling has been overdone and has left its shares trading at a very attractive price. Times may be hard for the bank right now, but the headwinds it is facing will ease eventually and its outlook will improve. In light of this, I think it is worth being patient and buying its shares with a long term view.
CSL Limited (ASX: CSL)
This global biotherapeutics company could be a great place to invest. I believe it is well-positioned to continue its positive form over the next decade due to its leading therapies, growing plasma collection network, and lucrative research and development (R&D) pipeline. CSL currently has a wide range of therapies under development which have the potential to generate significant revenues in the coming years.
Kogan.com Ltd (ASX: KGN)
A final option to consider is Kogan. I think the ecommerce company could be a market beater over the next 10 years. This is thanks to the continued shift to online shopping by consumers and the growing popularity of its offering. This has been evident during the pandemic, with Kogan reported explosive sales and earnings growth in March and April.
